Interferon-alpha for the hypereosinophilic syndrome
Zielinski, R.M.; Lawrence, W.D.
Annals of Internal Medicine 113(9): 716-718
1990
ISSN/ISBN: 0003-4819 PMID: 2088325 Document Number: 365677
Document emailed within 1 workday
Related Documents
Coutant, G.; Blétry, O.; Prin, L.; Hauteville, D.; de Puyfontaine, O.; Abgrall, J.F.; Godeau, P. 1993: Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases Annales de Medecine Interne 144(4): 243-250Acaba, L.; Mangual, A.; Vélez García, E. 2000: Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin e levels Boletin de la Asociacion Medica de Puerto Rico 92(4-8): 59-62
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Dhib, M.; Bakhache, E.; Postec, E.; Vanrenterghem, B.; Le Roy, F.; Azar, R.; François, A.; Boldron, A.; Amaria, R.; Ozenne, G.; Hermelin, A. 1996: Nephrotic syndrome complicating treatment with interferon alpha Presse Medicale 25(23): 1066-1068
Shiozawa, S.; Shiozawa, K.; Shimizu, S.; Tanaka, Y.; Morimoto, I.; Yoshihara, R.; Kuroki, Y.; Hashimoto, M.; Fujita, T. 1990: Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome British Journal of Rheumatology 29(1): 50-52
Grunfeld, C.; Kotler, D.P.; Shigenaga, J.K.; Doerrler, W.; Tierney, A.; Wang, J.; Pierson, R.N.; Feingold, K.R. 1991: Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome American Journal of Medicine 90(2): 154-162
García-Porrúa, C.; González-Gay, M.A.; Fernández-Lamelo, F.; Paz-Carreira, J.M.; Lavilla, E.; González-López, M.A. 1998: Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment Clinical and Experimental Rheumatology 16(1): 107-108
Suenaga, N.; Hayashi, F.; Miyauhi, N.; Nakamura, H.; Kitada, O.; Sugita, M.; Uematsu, K.; Kitaichi, M. 1991: A case of hypereosinophilic syndrome associated with pulmonary infarction and hepatic vein obstruction (Budd-Chiari syndrome) Nihon Kyobu Shikkan Gakkai Zasshi 29(2): 239-244
Sanli, H.; Akay, B.N.; Anadolu, R.; Ozcan, M.; Saral, S.; Akyol, A. 2011: The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome Journal of Drugs in Dermatology: Jdd 10(4): 403-408
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Corbillet, V.; Celerier, P.; Lebon, P.; Litoux, P.; Dreno, B. 1995: Development of interferon antibodies during the treatment of skin diseases with low-dose recombinant interferon alpha-2a Annales de Medecine Interne 146(6): 399-403
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Sayers, T.J.; Wiltrout, T.A.; McCormick, K.; Husted, C.; Wiltrout, R.H. 1990: Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Research 50(17): 5414-5420
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Grigorian, S.S.; Pritsker, A.D.; Onufrieva, E.K.; Chireshkin, D.G.; Ershov, F.I. 1991: The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis Voprosy Virusologii 36(5): 407-409
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171